OFLARB IV ###OFLOXACIN 200mg. IP + SODIUM CHLORIDE 0.9w/v IP

Oflarb IV is an intravenous infusion of ofloxacin 200 mg for bacterial infections needing treatment through a drip. Main uses: lower respiratory tract infections caused by susceptible bacteria, including pneumonia and flare-ups of long-term bronchitis; urinary tract infections caused by susceptible bacteria, including kidney infection; skin and soft tissue infections caused by susceptible bacteria; bone and joint infections caused by susceptible bacteria; blood stream infection (septicaemia) caused by susceptible bacteria.

Common side effects of Oflarb IV Infusion include nausea and vomiting; diarrhoea or loose stools; abdominal pain or discomfort; headache or dizziness; skin rash or itching; pain, redness or swelling at the infusion site. Get medical help at once if you notice sudden allergic reactions, including swelling of the face or throat and difficulty breathing, which need immediate treatment; tendon pain, swelling or rupture, especially of the heel; peripheral neuropathy (pain, burning, tingling, numbness or weakness, especially in the hands and feet), which can be serious and may last a long time; ofloxacin must be stopped and medical advice sought promptly if such symptoms appear.

Oflarb IV Infusion contains Ofloxacin 200 mg + Sodium Chloride 0.9w/v. Oflarb IV Infusion is given by a doctor or nurse, who decides the dose and how often it is given.

The MRP of Oflarb IV Infusion is ₹121.88 for a pack of 100ml. For chemists and distributors, the PTR is ₹92.86 and the PTS is ₹83.57.

Oflarb IV Infusion contains Ofloxacin 200 mg + Sodium Chloride 0.9w/v. It comes in a pack of 100ml.

Ofloxacin works by blocking the bacterial enzymes needed to copy and repair DNA, so the bacteria cannot multiply and are killed. Sodium Chloride 0.9% w/v serves as the sterile liquid vehicle that dissolves and delivers the medicine into the vein and helps keep the body's fluid and salt level steady during the infusion.

Must not be used in patients who are allergic to ofloxacin, to other fluoroquinolones or to any part of the infusion. Must not be used in patients with known myasthenia gravis, as fluoroquinolones can cause serious worsening of muscle weakness in this condition. Check with a doctor first if there is a history of epilepsy or other fits. Check with a doctor first in pregnancy, while breastfeeding, or in children and adolescents who are still growing. Stop and check with a doctor at once if tendon pain, swelling, nerve symptoms such as tingling or numbness, or severe diarrhoea appears during treatment.

Oflarb IV Infusion is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.